CASP3 and in situ carcinoma: As shown in Figure 4E, CASP3 and p53 significantly increased after DOX (p = 0.0091 and p = 0.0108, respectively) and CIS (p = 0.0024 and p = 0.0238, respectively) treatment (Figure 4G).